Literature DB >> 784890

Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes.

A S Fauci, K R Pratt.   

Abstract

A model for the detection of single cell antibody production by human tonsillar lymphocytes after stimulation with either sheep red blood cells (SRBC) or polyclonal B-cell activators has been described. The culture system is a modified Mishell-Dutton technique with certain critical factors identified. The assay is a sensitive and resproducible hemolysis-in-gel system employing an ultra-thin layer gel technique measuring plaque-forming cells (PFC) against SRBC targets. Several factors essential for optimal responses are described, but the critical feature of the culture system is the use of selected lots of human AB serum supplements which are extensively absorbed with SRBC. This removes a blocking factor present in most human serum which suppresses the B-cell response to SRBC targets after stimulation with either SRBC or several polyclonal B-cell activators. In addition, absorption of serum with SRBC eliminates the presence of artifactual plaques. Background PFC are extremely low and stimulated cultures show significant and reproducible responses. These studies provide a simple, sensitive, and reproducible model for probing the complex events associated with activation of human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 784890      PMCID: PMC2190408          DOI: 10.1084/jem.144.3.674

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

Review 2.  Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans.

Authors:  A Coutinho; G Möller; W Richter
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

3.  In vitro antibody formation by human tonsil lymphocytes.

Authors:  T Watanabe; K Yoshizaki; T Yagura; Y Yamamura
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

4.  Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators.

Authors:  E Gronowicz; A Coutinho; G Möller
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

Review 5.  Plaque forming cells: methodology and theory.

Authors:  N K Jerne; C Henry; A A Nordin; H Fuji; A M Koros; I Lefkovits
Journal:  Transplant Rev       Date:  1974

Review 6.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

7.  Responsiveness of lymphoid precursors to polyclonal B-cell activators.

Authors:  E Gronowicz; A Coutinho
Journal:  Scand J Immunol       Date:  1975-09       Impact factor: 3.487

8.  In vitro induction and measurement of hemolytic plaque forming cells in man.

Authors:  H M Dosch; E W Gelfand
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Purified protein derivative of tuberculin induces immunoglobulin production in normal mouse spleen cells.

Authors:  B S Nilsson; B M Sultzer; W W Bullock
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes.

Authors:  R S Geha; E Schneeberger; F S Rosen; E Merler
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  50 in total

1.  Depressed primary in vitro antibody response in rheumatoid arthritis.

Authors:  P Segond; J F Delfraissy; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

2.  Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.

Authors:  M Yasukawa; Y Kobayashi
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

3.  Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses.

Authors:  M Mitani; G J Cianciolo; R Snyderman; M Yasuda; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

4.  Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.

Authors:  R H Stevens; A Saxon
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

5.  Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

Authors:  J Touw; E M Langendijk; G L Stoner; A Belehu
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.

Authors:  B F Haynes; G S Eisenbarth; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

9.  The role of mitogens and antigens in the generation of antibody-producing human B lymphocytes.

Authors:  S G Pahwa; R A Good; M K Hoffmann
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

10.  Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation.

Authors:  D J Volkman; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.